Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach-Reference-Cited by-同舟云学术

Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach

Published:2021-08 Issue:8 Volume:141 Page:2028-2036.e2
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Kim Kevin B.^ORCID,Soroceanu Liliana^ORCID,de Semir David^ORCID,Millis Sherri Z.^ORCID,Ross Jeffrey^ORCID,Vosoughi Elham^ORCID,Dar Altaf A.^ORCID,Nosrati Mehdi^ORCID,Desprez Pierre-Yves^ORCID,Ice Ryan^ORCID,Chen Michelle^ORCID,Chetal Kashish^ORCID,Bhattacharjee Anukana^ORCID,Moretto John^ORCID,Leong Stanley P.^ORCID,Singer Mark I.^ORCID,Parrett Brian M.^ORCID,Minor David R.^ORCID,McAllister Sean^ORCID,Miller James R.^ORCID,Salomonis Nathan^ORCID,Kashani-Sabet Mohammed^ORCID

Funder

CPMC Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference44 articles.

1. Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON 2 study;Abida;Clin Cancer Res,2020

2. Lysyl oxidase expression and inhibition in uveal melanoma;Abourbih;Melanoma Res,2010

3. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair;Ashworth;J Clin Oncol,2008

4. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome;Bell;Science,1999

5. PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination;Bryant;EMBO J,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma;npj Precision Oncology;2024-09-05

2. miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK;Journal of Translational Medicine;2024-08-13

3. Transcriptome-Wide Association Study Reveals New Molecular Interactions Associated with Melanoma Pathogenesis;Cancers;2024-07-11

4. RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma;Investigational New Drugs;2023-12-10

5. Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies;Melanoma Research;2023-10-02